Raffles Family Office leads Series B funding round for cancer screening and early-detection solutions developer Cellomics

Pan-Asian multi-family office strengthens private equity holdings with stake in Hong Kong biotech firm poised to advance precision oncology industry. Raffles Family Office (RFO) has bolstered its burgeoning private equity portfolio with an investment in Cellomics, a Hong Kong-based biotechnology company pursuing the development and commercialisation of cancer screening and…